{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:14:41Z","timestamp":1789643681950,"version":"4.0.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017655","name":"Incyte Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jid.2025.10.613","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:38:23Z","timestamp":1763645903000},"page":"1578-1585.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ruxolitinib cream demonstrated rapid reductions in itch and atopic dermatitis signs that correlated with biomarkers"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5927-6587","authenticated-orcid":false,"given":"Robert","family":"Bissonnette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Saint-Cyr Proulx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Correa da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeriel","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4694-2795","authenticated-orcid":false,"given":"Haobo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haq","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Halden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5021-9412","authenticated-orcid":false,"given":"Diana","family":"Stefani-Hunyady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-6826","authenticated-orcid":false,"given":"Angelina","family":"Volkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.10.613_bib1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMoa2019380","article-title":"Abrocitinib versus placebo or dupilumab for atopic dermatitis","volume":"384","author":"Bieber","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.10.613_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jdv.18571","article-title":"Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis","volume":"37","author":"Blauvelt","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.10.613_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2022.09.010","article-title":"Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream: a pooled analysis from two randomized phase 3 studies","volume":"88","author":"Blauvelt","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jamadermatol.2021.3023","article-title":"Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis: a randomized clinical trial","volume":"157","author":"Blauvelt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib5","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imbio.2004.04.005","article-title":"The role of matrix metalloproteinase 7 in innate immunity","volume":"209","author":"Burke","year":"2004","journal-title":"Immunobiology"},{"key":"10.1016\/j.jid.2025.10.613_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-021-00857-w","article-title":"What does elevated TARC\/CCL17 expression tell us about eosinophilic disorders?","volume":"43","author":"Catherine","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2025.10.613_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","article-title":"A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1","volume":"133","author":"Cevikbas","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/archpedi.159.8.745","article-title":"The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis","volume":"159","author":"Chamlin","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jid.2025.10.613_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cei.13013","article-title":"Current insights into the role of human \u03b2-defensins in atopic dermatitis","volume":"190","author":"Chieosilapatham","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib11","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1111\/j.1468-3083.2012.04578.x","article-title":"Relationship between itch and psychological status of patients with atopic dermatitis","volume":"27","author":"Chrostowska-Plak","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.10.613_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/all.15845","article-title":"Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies","volume":"79","author":"Del Duca","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jid.2025.10.613_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib14","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/jid.2011.140","article-title":"Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation","volume":"131","author":"Fridman","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib15","article-title":"Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a systematic review and meta-analysis","volume":"9","author":"Gao","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jid.2025.10.613_bib16","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/all.15969","article-title":"Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis","volume":"79","author":"Guttman-Yassky","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jid.2025.10.613_bib18","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.5346","article-title":"Itch and Janus kinase inhibitors","volume":"103","author":"Han","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2025.10.613_bib19","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3389\/fimmu.2020.01768","article-title":"Tape-strip proteomic profiling of atopic dermatitis on dupilumab identifies minimally invasive biomarkers","volume":"11","author":"He","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.anai.2018.02.012","article-title":"JAK\/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease","volume":"120","author":"Howell","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib22","doi-asserted-by":"crossref","first-page":"s5","DOI":"10.36849\/JDD.49142","article-title":"INDIVIDUAL ARTICLE: Appraisal of ruxolitinib 1.5% cream as a first-line topical therapeutic agent for adolescents and adults with mild-to-moderate atopic dermatitis","volume":"24","author":"Issa","year":"2025","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib23","doi-asserted-by":"crossref","first-page":"s16","DOI":"10.36849\/JDD.49143","article-title":"Ruxolitinib 1.5% cream and the \"boxed warning paradox\": reappraisal of safety through the lens of pharmacokinetics","volume":"24","author":"Issa","year":"2025","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mai.2001.113237","article-title":"Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity","volume":"107","author":"Kakinuma","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/942375","article-title":"Role of macrophages in the pathogenesis of atopic dermatitis","volume":"2013","author":"Kasraie","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jid.2025.10.613_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jaci.2019.08.042","article-title":"Treatment of atopic dermatitis with ruxolitinib cream (JAK1\/JAK2 inhibitor) or triamcinolone cream","volume":"145","author":"Kim","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib28","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s12325-021-01630-z","article-title":"Psychosocial comorbidities and health status among adults with moderate-to-severe atopic dermatitis: a 2017 US national health and wellness survey analysis","volume":"38","author":"Kwatra","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jid.2025.10.613_bib29","article-title":"Itch in atopic dermatitis - what is new?","volume":"8","author":"Legat","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2025.10.613_bib30","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.4049\/jimmunol.1600126","article-title":"Expression of IL-22 in the skin causes Th2-biased immunity, epidermal barrier dysfunction, and pruritus via stimulating epithelial Th2 cytokines and the GRP pathway","volume":"198","author":"Lou","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.it.2018.10.001","article-title":"The itch-scratch cycle: a neuroimmune perspective","volume":"39","author":"Mack","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib32","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/DER.0000000000000764","article-title":"Transcriptomic profiling of tape-strips from moderate to severe atopic dermatitis patients treated with dupilumab","volume":"32","author":"Mikhaylov","year":"2021","journal-title":"Dermatitis"},{"key":"10.1016\/j.jid.2025.10.613_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaci.2023.05.004","article-title":"Basic mechanisms of itch","volume":"152","author":"Misery","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5114\/pdia.2014.40920","article-title":"Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis","volume":"31","author":"Nedoszytko","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jid.2025.10.613_bib35","first-page":"949","article-title":"FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro","volume":"113","author":"Novak","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jid.2025.10.613_bib37","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2340\/00015555-0933","article-title":"Association of stress with symptoms of atopic dermatitis","volume":"90","author":"Oh","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2025.10.613_bib38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaad.2022.09.060","article-title":"Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: results from two phase 3 studies","volume":"88","author":"Papp","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2021.04.085","article-title":"Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from 2 phase 3, randomized, double-blind studies","volume":"85","author":"Papp","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119889","article-title":"Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigs","volume":"590","author":"Persaud","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jid.2025.10.613_bib41","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quint\u00e1s-Cardama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jid.2025.10.613_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(22)01199-0","article-title":"Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial","volume":"400","author":"Reich","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2025.10.613_bib43","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","article-title":"Biomarkers in atopic dermatitis-a review on behalf of the International Eczema Council","volume":"147","author":"Renert-Yuval","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib44","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.0901860","article-title":"IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation","volume":"184","author":"Sehra","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib46","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s13555-023-01000-3","article-title":"Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis without topical corticosteroids: an updated network meta-analysis","volume":"13","author":"Silverberg","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2025.10.613_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2310633","article-title":"Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies","volume":"35","author":"Simpson","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2025.10.613_bib48","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.alit.2017.02.015","article-title":"Roles of alternatively activated M2 macrophages in allergic contact dermatitis","volume":"66","author":"Suzuki","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jid.2025.10.613_bib50","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2340\/00015555-3158","article-title":"Validation of a comprehensive set of pruritus assessment instruments: the Chronic Pruritus Tools Questionnaire PRURITOOLS","volume":"99","author":"Verweyen","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2025.10.613_bib51","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/cea.12979","article-title":"Identification of unique proteomic signatures in allergic and non-allergic skin disease","volume":"47","author":"Wang","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jid.2025.10.613_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jid.2025.10.613_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.17744","article-title":"Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis","volume":"181","author":"Yosipovitch","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.10.613_bib54","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaci.2018.09.005","article-title":"Itch: from mechanism to (novel) therapeutic approaches","volume":"142","author":"Yosipovitch","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.10.613_bib55","article-title":"Global gene regulation during activation of immunoglobulin class switching in human B cells","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2503550X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X2503550X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:08:03Z","timestamp":1779998883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X2503550X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0022202X2503550X"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.10.613","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ruxolitinib cream demonstrated rapid reductions in itch and atopic dermatitis signs that correlated with biomarkers","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.10.613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}